<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Andrew Bean, Sebastian Weber, Lukas Widmer" />

<meta name="date" content="2021-05-07" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber, Lukas Widmer</h4>
<h4 class="date">2021-05-07</h4>



<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to ensure patient safety during trial conduct by supporting dose-escalation decisions. In addition, the model can support estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>Whereas traditional dose escalation designs, such as the 3+3 design, base the dosing decisions on predefined rules about the number of DLTs in the last one or two cohorts at the current dose, model-based designs such as those using Bayesian Logistic Regression Models (BLRMs) endeavor to model the dose-toxicity relationship as a continuous curve, and allow the model to guide dosing decisions. In this way, all available data contributes to the dosing decisions. Furthermore, extensions to the BLRM approach can support inclusion of available historical data on the compound(s) involved.</p>
<p>The package supports incorporation of historical data through a Meta-Analytic-Combined (MAC) framework [1], which stratifies these heterogeneous sources of information through a hierarchical model. Additionally, it allows the use of EXchangeable/Non-EXchangeable (EX/NEX) priors to manage the amount of information-sharing across subgroups of historical and/or concurrent sources of data.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb1-2" title="2"><span class="kw">library</span>(dplyr)  <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb1-3" title="3"><span class="kw">library</span>(tidyr)  <span class="co">## defines expand_grid</span></a>
<a class="sourceLine" id="cb1-4" title="4"><span class="kw">library</span>(tibble) <span class="co">## for tibbles</span></a></code></pre></div>
</div>
<div id="example-use-case" class="section level2">
<h2>Example use-case</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb3-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<div id="setting-up-the-trial-design" class="section level3">
<h3>Setting up the trial design</h3>
<p>The function <code>blrm_trial</code> provides an object-oriented framework for operationalizing the dose-escalation trial design. This framework is intended as a convenient wrapper for the main model-fitting engine of the package, the <code>blrm_exnex()</code> function. The latter allows additional flexibility for specifying the functional form of the model, but <code>blrm_trial</code> covers the most common use-cases. This introductory vignette highlights <code>blrm_trial</code> in lieu of <code>blrm_exnex</code>; the reader is referred to the help-page of the function<code>?blrm_exnex</code> for more details.</p>
<p>One begins with <code>blrm_trial</code> by specifying three key design elements:</p>
<ul>
<li>The dose-toxicity data</li>
<li>Information about the study drugs</li>
<li>The provisional dose levels to be studied during the escalation trial</li>
</ul>
<p>Information about the study drugs is encoded through a <code>tibble</code> as below. This includes the names of the study-drugs, the reference doses (see [3] or <code>?blrm_exnex</code> to understand the role this choice plays in the model specification), the dosing units, and (optionally) the a priori expected DLT rate for each study drug given individually at the respective reference doses.</p>
<p>All design information for the study described in [1] is also included as built-in datasets, which are part of the <code>OncoBayes2</code> package.</p>
<div id="drug-info" class="section level4">
<h4>Drug info</h4>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">kable</span>(drug_info_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">drug_name</th>
<th align="right">dose_ref</th>
<th align="left">dose_unit</th>
<th align="right">reference_p_dlt</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">drug_A</td>
<td align="right">300</td>
<td align="left">mg</td>
<td align="right">0.1</td>
</tr>
<tr class="even">
<td align="left">drug_B</td>
<td align="right">960</td>
<td align="left">mg</td>
<td align="right">0.1</td>
</tr>
</tbody>
</table>
</div>
<div id="dose-info" class="section level4">
<h4>Dose info</h4>
<p>The provisional dose levels are specified as below. For conciseness, we begin by fixing the dose level of drug A in these provisional doses.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">dose_info &lt;-<span class="st"> </span><span class="kw">filter</span>(dose_info_combo2, group_id <span class="op">==</span><span class="st"> &quot;trial_AB&quot;</span>, drug_A <span class="op">==</span><span class="st"> </span><span class="dv">3</span>)</a>
<a class="sourceLine" id="cb6-2" title="2"><span class="kw">kable</span>(dose_info)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">dose_id</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">22</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">400</td>
<td align="right">23</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">600</td>
<td align="right">24</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">800</td>
<td align="right">25</td>
</tr>
</tbody>
</table>
</div>
<div id="initializing-a-blrm_trial" class="section level4">
<h4>Initializing a <code>blrm_trial</code></h4>
<p>Together with the data described in the previous section, these objects can be used to initialize a <code>blrm_trial</code> object.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">combo2_trial_setup &lt;-<span class="st"> </span><span class="kw">blrm_trial</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_info =</span> drug_info_combo2,</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">dose_info =</span> dose_info,</a>
<a class="sourceLine" id="cb7-5" title="5">  <span class="dt">simplified_prior =</span> <span class="ot">FALSE</span></a>
<a class="sourceLine" id="cb7-6" title="6">)</a></code></pre></div>
<pre><code>## No stratum defined - assigning all groups to single stratum &quot;all&quot;</code></pre>
<pre><code>## Please configure blrm_exnex using the update() function.</code></pre>
</div>
</div>
<div id="specifying-the-prior-and-fitting-the-model" class="section level3">
<h3>Specifying the prior and fitting the model</h3>
<p>At this point, the trial design has been initialized. However, in the absence of <code>simplified_prior = TRUE</code>, we have not yet specified the prior distribution for the dose-toxicity model.</p>
<p>OncoBayes2 provides two methods for completing the model specification:</p>
<ol style="list-style-type: decimal">
<li><p>Use <code>simplified_prior = TRUE</code>, which employs a package-default prior distribution, subject to a small number of optional arguments controlling the details.</p></li>
<li><p>Provide a full prior specification to be passed to the main model-fitting engine of OncoBayes2: the <code>blrm_exnex</code> function.</p></li>
</ol>
<p>For illustrative purposes, here we highlight method #1. See <code>?&#39;example-combo2_trial&#39;</code> for an example of #2. The below choice of prior broadly follows the case study in [4], although we slightly deviate from the model in [4] by allowing an EXchangeable/Non-EXchangeable prior for the drug components.</p>
<p>To employ the simplified prior, and fit the model with MCMC:</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1">combo2_trial_start &lt;-<span class="st"> </span><span class="kw">blrm_trial</span>(</a>
<a class="sourceLine" id="cb10-2" title="2">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb10-3" title="3">  <span class="dt">drug_info =</span> drug_info_combo2,</a>
<a class="sourceLine" id="cb10-4" title="4">  <span class="dt">dose_info =</span> dose_info,</a>
<a class="sourceLine" id="cb10-5" title="5">  <span class="dt">simplified_prior =</span> <span class="ot">TRUE</span>,</a>
<a class="sourceLine" id="cb10-6" title="6">  <span class="dt">EX_prob_comp_hist =</span> <span class="fl">0.8</span>,</a>
<a class="sourceLine" id="cb10-7" title="7">  <span class="dt">EX_prob_comp_new =</span> <span class="dv">1</span></a>
<a class="sourceLine" id="cb10-8" title="8">)</a></code></pre></div>
<p>Now, the object <code>combo2_trial_start</code> contains the posterior model fit, in addition to the trial design details. Next we highlight the main methods for extracting relevant information from it.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1"><span class="kw">prior_summary</span>(combo2_trial_start) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of provisional dose levels. To obtain these summaries for the provisional doses specified previously, we simply write:</p>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">kable</span>(<span class="kw">summary</span>(combo2_trial_start, <span class="st">&quot;dose_prediction&quot;</span>), <span class="dt">digits =</span> <span class="dv">2</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">dose_id</th>
<th align="left">stratum_id</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">22</td>
<td align="left">all</td>
<td align="right">0.08</td>
<td align="right">0.12</td>
<td align="right">0.00</td>
<td align="right">0.04</td>
<td align="right">0.44</td>
<td align="right">0.86</td>
<td align="right">0.10</td>
<td align="right">0.04</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">400</td>
<td align="right">23</td>
<td align="left">all</td>
<td align="right">0.14</td>
<td align="right">0.16</td>
<td align="right">0.00</td>
<td align="right">0.09</td>
<td align="right">0.63</td>
<td align="right">0.72</td>
<td align="right">0.18</td>
<td align="right">0.10</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">600</td>
<td align="right">24</td>
<td align="left">all</td>
<td align="right">0.16</td>
<td align="right">0.17</td>
<td align="right">0.01</td>
<td align="right">0.11</td>
<td align="right">0.68</td>
<td align="right">0.65</td>
<td align="right">0.23</td>
<td align="right">0.12</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">800</td>
<td align="right">25</td>
<td align="left">all</td>
<td align="right">0.20</td>
<td align="right">0.18</td>
<td align="right">0.02</td>
<td align="right">0.15</td>
<td align="right">0.73</td>
<td align="right">0.53</td>
<td align="right">0.31</td>
<td align="right">0.16</td>
<td align="left">TRUE</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have unacceptable high risk of toxicity. For example, according to the escalation with overdose control (EWOC) design criteria [3], one would compute the posterior probability that each dose is excessively toxic (column <code>prob_overdose</code>; note that the definition of “excessively toxic” is encoded in the <code>blrm_trial</code> object through the <code>interval_prob</code> argument), and take as eligible doses only those where this probability does not exceed 25% (column <code>ewoc_ok</code>).</p>
</div>
<div id="posterior-predictive-summaries" class="section level3">
<h3>Posterior predictive summaries</h3>
<p>The BLRM allows a principled approach to predicting the number of DLTs that may be observed in a future cohort. This may be a key estimand for understanding and limiting the toxicity risk to patients. For example, suppose a candidate starting dose for the new trial <code>trial_AB</code> is 3 mg of Drug A + 400 mg of Drug B. We may wish to check that at this dose, the estimated probability of 2 or more DLTs out of an initial cohort of 3 to 6 patients is sufficiently low.</p>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1">candidate_starting_dose &lt;-<span class="st"> </span><span class="kw">summary</span>(combo2_trial_start, <span class="st">&quot;dose_info&quot;</span>) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb13-2" title="2"><span class="st">  </span><span class="kw">filter</span>(drug_A <span class="op">==</span><span class="st"> </span><span class="dv">3</span>, drug_B <span class="op">==</span><span class="st"> </span><span class="dv">400</span>) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb13-3" title="3"><span class="st">  </span><span class="kw">expand_grid</span>(<span class="dt">num_patients =</span> <span class="dv">3</span><span class="op">:</span><span class="dv">6</span>) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb13-4" title="4"><span class="st">  </span><span class="kw">mutate</span>(<span class="dt">num_toxicities =</span> <span class="dv">0</span>)</a>
<a class="sourceLine" id="cb13-5" title="5"></a>
<a class="sourceLine" id="cb13-6" title="6">pp_summary &lt;-<span class="st"> </span><span class="kw">summary</span>(combo2_trial_start, <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="op">-</span><span class="dv">1</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="dv">6</span>), <span class="dt">predictive =</span> <span class="ot">TRUE</span>,</a>
<a class="sourceLine" id="cb13-7" title="7">                      <span class="dt">newdata =</span> candidate_starting_dose)</a>
<a class="sourceLine" id="cb13-8" title="8"></a>
<a class="sourceLine" id="cb13-9" title="9"><span class="kw">kable</span>(<span class="kw">bind_cols</span>(<span class="kw">select</span>(candidate_starting_dose, num_patients),</a>
<a class="sourceLine" id="cb13-10" title="10">                <span class="kw">select</span>(pp_summary, <span class="kw">ends_with</span>(<span class="st">&quot;]&quot;</span>))), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="right">num_patients</th>
<th align="right">(-1,0]</th>
<th align="right">(0,1]</th>
<th align="right">(1,6]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">3</td>
<td align="right">0.698</td>
<td align="right">0.216</td>
<td align="right">0.086</td>
</tr>
<tr class="even">
<td align="right">4</td>
<td align="right">0.640</td>
<td align="right">0.233</td>
<td align="right">0.127</td>
</tr>
<tr class="odd">
<td align="right">5</td>
<td align="right">0.591</td>
<td align="right">0.243</td>
<td align="right">0.166</td>
</tr>
<tr class="even">
<td align="right">6</td>
<td align="right">0.550</td>
<td align="right">0.248</td>
<td align="right">0.202</td>
</tr>
</tbody>
</table>
<p>This tells us that for the initial cohort, according to the model, the chance of two or more patients developing DLTs ranges from 8.6% to 20.2%, depending on the number of patients enrolled.</p>
</div>
<div id="updating-the-model-with-new-data" class="section level3">
<h3>Updating the model with new data</h3>
<p>Dose-escalation designs are adaptive in nature, as dosing decisions are made after each sequential cohort. The model must be updated after each new enrollment. If a new cohort of patients is observed, say:</p>
<div class="sourceCode" id="cb14"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb14-1" title="1">new_cohort &lt;-<span class="st"> </span><span class="kw">tibble</span>(<span class="dt">group_id =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb14-2" title="2">                     <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb14-3" title="3">                     <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb14-4" title="4">                     <span class="dt">num_patients =</span> <span class="dv">5</span>,</a>
<a class="sourceLine" id="cb14-5" title="5">                     <span class="dt">num_toxicities =</span> <span class="dv">1</span>)</a></code></pre></div>
<p>One can update the model to incorporate this new information using <code>update()</code> with <code>add_data</code> equal to the new cohort:</p>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb15-1" title="1">combo2_trial_update &lt;-<span class="st"> </span><span class="kw">update</span>(combo2_trial_start, <span class="dt">add_data =</span> new_cohort)</a></code></pre></div>
<p>This yields a new <code>blrm_trial</code> object with updated data and posterior summaries. Below is the method for obtaining posterior estimates at the next highest dose of drug A.</p>
<div class="sourceCode" id="cb16"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb16-1" title="1"><span class="kw">kable</span>(<span class="kw">summary</span>(combo2_trial_update, <span class="st">&quot;newdata_prediction&quot;</span>,</a>
<a class="sourceLine" id="cb16-2" title="2">              <span class="dt">newdata =</span> <span class="kw">tibble</span>(<span class="dt">group_id =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb16-3" title="3">                               <span class="dt">drug_A =</span> <span class="fl">4.5</span>,</a>
<a class="sourceLine" id="cb16-4" title="4">                               <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>))), <span class="dt">digits =</span> <span class="dv">2</span>)</a></code></pre></div>
<pre><code>## stratum_id not given, but only one stratum defined. Assigning first stratum.</code></pre>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="left">stratum_id</th>
<th align="right">dose_id</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.16</td>
<td align="right">0.12</td>
<td align="right">0.02</td>
<td align="right">0.13</td>
<td align="right">0.47</td>
<td align="right">0.59</td>
<td align="right">0.31</td>
<td align="right">0.10</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.19</td>
<td align="right">0.13</td>
<td align="right">0.04</td>
<td align="right">0.17</td>
<td align="right">0.52</td>
<td align="right">0.48</td>
<td align="right">0.39</td>
<td align="right">0.13</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.23</td>
<td align="right">0.14</td>
<td align="right">0.05</td>
<td align="right">0.20</td>
<td align="right">0.58</td>
<td align="right">0.35</td>
<td align="right">0.45</td>
<td align="right">0.20</td>
<td align="left">TRUE</td>
</tr>
</tbody>
</table>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>It may be of interest to test prospectively how this model responds in various scenarios for upcoming cohorts.</p>
<p>This can be done easily by again using <code>update()</code> with the <code>add_data</code> argument. In the code below, we explore 3 possible outcomes for a subsequent cohort enrolled at 3 mg Drug A + 800 mg Drug B, and review the model’s inference at adjacent doses.</p>
<div class="sourceCode" id="cb18"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb18-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb18-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb18-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb18-4" title="4">  <span class="dt">group_id  =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb18-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb18-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">800</span>,</a>
<a class="sourceLine" id="cb18-7" title="7">  <span class="dt">num_patients =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb18-8" title="8">  <span class="dt">num_toxicities =</span> <span class="dv">0</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb18-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">3</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste</span>(<span class="dv">0</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb18-10" title="10"></a>
<a class="sourceLine" id="cb18-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb18-12" title="12">  <span class="dt">group_id =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb18-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb18-14" title="14">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb18-15" title="15">)</a>
<a class="sourceLine" id="cb18-16" title="16"></a>
<a class="sourceLine" id="cb18-17" title="17"></a>
<a class="sourceLine" id="cb18-18" title="18">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata) {</a>
<a class="sourceLine" id="cb18-19" title="19">  </a>
<a class="sourceLine" id="cb18-20" title="20">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb18-21" title="21">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(combo2_trial_update, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb18-22" title="22">  </a>
<a class="sourceLine" id="cb18-23" title="23">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb18-24" title="24">  <span class="kw">summary</span>(scenario_fit, <span class="st">&quot;newdata_prediction&quot;</span>, <span class="dt">newdata =</span> candidate_doses)</a>
<a class="sourceLine" id="cb18-25" title="25">  </a>
<a class="sourceLine" id="cb18-26" title="26">})</a></code></pre></div>
<table>
<caption>Model inference when 0 DLTs are observed in the next cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="left">stratum_id</th>
<th align="right">dose_id</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="left">all</td>
<td align="right">24</td>
<td align="right">0.14</td>
<td align="right">0.09</td>
<td align="right">0.02</td>
<td align="right">0.12</td>
<td align="right">0.35</td>
<td align="right">0.68</td>
<td align="right">0.29</td>
<td align="right">0.03</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="left">all</td>
<td align="right">25</td>
<td align="right">0.17</td>
<td align="right">0.10</td>
<td align="right">0.04</td>
<td align="right">0.15</td>
<td align="right">0.40</td>
<td align="right">0.54</td>
<td align="right">0.40</td>
<td align="right">0.06</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.15</td>
<td align="right">0.09</td>
<td align="right">0.03</td>
<td align="right">0.13</td>
<td align="right">0.37</td>
<td align="right">0.63</td>
<td align="right">0.32</td>
<td align="right">0.05</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.18</td>
<td align="right">0.10</td>
<td align="right">0.04</td>
<td align="right">0.16</td>
<td align="right">0.42</td>
<td align="right">0.49</td>
<td align="right">0.43</td>
<td align="right">0.08</td>
<td align="left">TRUE</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 1 DLT is observed in the next cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="left">stratum_id</th>
<th align="right">dose_id</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="left">all</td>
<td align="right">24</td>
<td align="right">0.20</td>
<td align="right">0.11</td>
<td align="right">0.05</td>
<td align="right">0.18</td>
<td align="right">0.47</td>
<td align="right">0.42</td>
<td align="right">0.46</td>
<td align="right">0.12</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="left">all</td>
<td align="right">25</td>
<td align="right">0.24</td>
<td align="right">0.12</td>
<td align="right">0.07</td>
<td align="right">0.22</td>
<td align="right">0.53</td>
<td align="right">0.28</td>
<td align="right">0.52</td>
<td align="right">0.21</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.21</td>
<td align="right">0.11</td>
<td align="right">0.05</td>
<td align="right">0.19</td>
<td align="right">0.49</td>
<td align="right">0.37</td>
<td align="right">0.48</td>
<td align="right">0.14</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.25</td>
<td align="right">0.12</td>
<td align="right">0.07</td>
<td align="right">0.23</td>
<td align="right">0.54</td>
<td align="right">0.23</td>
<td align="right">0.53</td>
<td align="right">0.24</td>
<td align="left">TRUE</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 2 DLTs are observed in the next cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="left">stratum_id</th>
<th align="right">dose_id</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="left">all</td>
<td align="right">24</td>
<td align="right">0.28</td>
<td align="right">0.14</td>
<td align="right">0.07</td>
<td align="right">0.25</td>
<td align="right">0.60</td>
<td align="right">0.21</td>
<td align="right">0.48</td>
<td align="right">0.31</td>
<td align="left">FALSE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="left">all</td>
<td align="right">25</td>
<td align="right">0.34</td>
<td align="right">0.15</td>
<td align="right">0.11</td>
<td align="right">0.31</td>
<td align="right">0.71</td>
<td align="right">0.10</td>
<td align="right">0.45</td>
<td align="right">0.45</td>
<td align="left">FALSE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.29</td>
<td align="right">0.14</td>
<td align="right">0.08</td>
<td align="right">0.27</td>
<td align="right">0.62</td>
<td align="right">0.18</td>
<td align="right">0.47</td>
<td align="right">0.35</td>
<td align="left">FALSE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.35</td>
<td align="right">0.15</td>
<td align="right">0.12</td>
<td align="right">0.33</td>
<td align="right">0.71</td>
<td align="right">0.09</td>
<td align="right">0.42</td>
<td align="right">0.50</td>
<td align="left">FALSE</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example" class="section level2">
<h2>Continuation of example</h2>
<p>In the example of [1], at the time of completion of <code>trial_AB</code>, the following additional data was observed.</p>
<div class="sourceCode" id="cb19"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb19-1" title="1"><span class="kw">kable</span>(<span class="kw">filter</span>(codata_combo2, cohort_time <span class="op">&gt;</span><span class="st"> </span><span class="dv">0</span>))</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Numerous toxicities were observed in the concurrent <code>IIT</code> study. Through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. Note that we use the <code>update</code> function differently than before, since we specify the entire data-set now we use the <code>data</code> argument.</p>
<div class="sourceCode" id="cb20"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb20-1" title="1">final_fit &lt;-<span class="st"> </span><span class="kw">update</span>(combo2_trial_start, <span class="dt">data =</span> codata_combo2)</a></code></pre></div>
<p>Model results can be visualized using package functions. See <code>?plot_toxicity_curve</code> for details.</p>
<div class="sourceCode" id="cb21"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb21-1" title="1"><span class="kw">plot_toxicity_curve</span>(final_fit, <span class="dt">x =</span> <span class="kw">vars</span>(drug_B), <span class="dt">group =</span> <span class="kw">vars</span>(group_id, drug_A),</a>
<a class="sourceLine" id="cb21-2" title="2">                    <span class="dt">facet_args =</span> <span class="kw">list</span>(<span class="dt">ncol =</span> <span class="dv">1</span>))</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb22"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb22-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
## 
## locale:
## [1] C
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tibble_2.1.3     tidyr_1.0.0      dplyr_0.8.3      ggplot2_3.2.1   
## [5] knitr_1.25       OncoBayes2_0.7-0 Rcpp_1.0.2      
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.3       tidyselect_0.2.5   xfun_0.10         
##  [4] purrr_0.3.3        colorspace_1.4-1   vctrs_0.2.0       
##  [7] htmltools_0.4.0    stats4_3.6.1       loo_2.1.0         
## [10] yaml_2.2.0         rlang_0.4.0        pkgbuild_1.0.6    
## [13] pillar_1.4.2       glue_1.3.1         withr_2.1.2       
## [16] matrixStats_0.55.0 lifecycle_0.1.0    plyr_1.8.4        
## [19] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0      
## [22] codetools_0.2-16   evaluate_0.14      labeling_0.3      
## [25] inline_0.3.15      callr_3.3.2        ps_1.3.0          
## [28] parallel_3.6.1     bayesplot_1.7.0    rstantools_2.0.0  
## [31] highr_0.8          scales_1.0.0       backports_1.1.5   
## [34] checkmate_1.9.4    StanHeaders_2.19.2 abind_1.4-5       
## [37] gridExtra_2.3      digest_0.6.21      stringi_1.4.3     
## [40] processx_3.4.1     grid_3.6.1         cli_1.1.0         
## [43] tools_3.6.1        magrittr_1.5       lazyeval_0.2.2    
## [46] Formula_1.2-3      crayon_1.3.4       pkgconfig_2.0.3   
## [49] zeallot_0.1.0      prettyunits_1.0.2  ggridges_0.5.1    
## [52] assertthat_0.2.1   rmarkdown_1.16     R6_2.4.0          
## [55] compiler_3.6.1</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
